1,3-Bis-(2-aza-1-oxo-8-(sodium(5-acetamido-3,5,9-trideoxy-9-(4-phenylbenzamido)-Dglycero-alpha-D-galacto-non-2-ulopyranosyloxyonate))-5-thia-octyl)benzene

ID: ALA5186602

Chembl Id: CHEMBL5186602

PubChem CID: 168278895

Max Phase: Preclinical

Molecular Formula: C66H78N6Na2O20S2

Molecular Weight: 1341.52

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CNC(=O)c2ccc(-c3ccccc3)cc2)O[C@@](OCCCSCCNC(=O)c2cccc(C(=O)NCCSCCCO[C@]3(C(=O)[O-])C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CNC(=O)c4ccc(-c5ccccc5)cc4)O3)c2)(C(=O)[O-])C[C@@H]1O.[Na+].[Na+]

Standard InChI:  InChI=1S/C66H80N6O20S2.2Na/c1-39(73)71-53-49(75)35-65(63(85)86,91-57(53)55(79)51(77)37-69-59(81)45-22-18-43(19-23-45)41-12-5-3-6-13-41)89-28-10-30-93-32-26-67-61(83)47-16-9-17-48(34-47)62(84)68-27-33-94-31-11-29-90-66(64(87)88)36-50(76)54(72-40(2)74)58(92-66)56(80)52(78)38-70-60(82)46-24-20-44(21-25-46)42-14-7-4-8-15-42;;/h3-9,12-25,34,49-58,75-80H,10-11,26-33,35-38H2,1-2H3,(H,67,83)(H,68,84)(H,69,81)(H,70,82)(H,71,73)(H,72,74)(H,85,86)(H,87,88);;/q;2*+1/p-2/t49-,50-,51+,52+,53+,54+,55+,56+,57+,58+,65+,66+;;/m0../s1

Standard InChI Key:  YWIGOTPUYMEGJF-OKQIABBQSA-L

Associated Targets(Human)

CD22 Tclin CD22 (125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1341.52Molecular Weight (Monoisotopic): 1340.4869AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Prescher H, Schweizer A, Frank M, Kuhfeldt E, Ring J, Nitschke L..  (2022)  Targeting Human CD22/Siglec-2 with Dimeric Sialosides as Novel Oligosaccharide Mimetics.,  65  (15.0): [PMID:35881556] [10.1021/acs.jmedchem.2c00765]

Source